24 May 2024
CNN recently spotlighted Labcorp’s groundbreaking first-trimester blood test, which allows clinicians to assess a pregnant patient’s risk for developing preeclampsia—a potentially life-threatening pregnancy complication—months earlier than ever before. Dr. Brian Caveney, Labcorp’s Chief Medical and Scientific Officer, explained that this innovative screening tool can help identify at-risk patients as early as 11 weeks into pregnancy, supporting more proactive care and potentially preventing severe outcomes for both mothers and babies. Read the full article on CNN to learn how Labcorp’s latest advance is shaping the future of maternal health.